Annual Computation Method. 1. Subject to Section 2.5.6, for any Target Year, if the EBIT CAGR, as measured against the Baseline EBIT, is: i. less than 4.5% for such Target Year, the Contingent Purchase Price due to Seller for such Target Year shall be zero ($0). ii. at least 4.5% and up to 9% for such Target Year, the Contingent Purchase Price due to Seller for such Target Year will range from $488,889 to $1,222,221, determined in accordance with Schedule 2.5. iii. equal to or greater than 9% for such Target Year, the Contingent Purchase Price due to Seller for such Target Year will be $1,222,222. 2. Subject to Section 2.5.6, if the increase in EBIT is at least 9% for each and every Target Year, as measured against EBIT for the immediately preceding twelve month period ending July 31, then, in addition to the amount of Contingent Purchase Price otherwise payable under this Section 2.5.2, Seller shall be entitled at the end of the Third Target Year, to an additional payment of Contingent Purchase Price equal to $333,333.
Appears in 2 contracts
Samples: Stock Purchase Agreement (Cantel Medical Corp), Stock Purchase Agreement (Cantel Medical Corp)
Annual Computation Method. 1. Subject to Section 2.5.6, for any Target Year, if the EBIT CAGR, as measured against the Baseline EBIT, is:
i. less than 4.5% for such Target Year, the Contingent Purchase Price due to Seller for such Target Year shall be zero ($0).
ii. at least 4.5% and up to 9% for such Target Year, the Contingent Purchase Price due to Seller for such Target Year will range from $488,889 117,195 to $1,222,221292,988, determined in accordance with Schedule 2.5.
iii. equal to or greater than 9% for such Target Year, the Contingent Purchase Price due to Seller for such Target Year will be $1,222,222292,987.
2. Subject to Section 2.5.6, if the increase in EBIT is at least 9% for each and every Target Year, as measured against EBIT for the immediately preceding twelve month period ending July 31, then, in addition to the amount of Contingent Purchase Price otherwise payable under this Section 2.5.2, Seller shall be entitled at the end of the Third Target Year, to an additional payment of Contingent Purchase Price equal to $333,33379,906.
Appears in 1 contract
Annual Computation Method. 1. Subject to Section 2.5.6, for any Target Year, if the EBIT CAGR, as measured against the Baseline EBIT, is:
i. less than 4.5% for such Target Year, the Contingent Purchase Price due to Seller for such Target Year shall be zero ($0).
ii. at least 4.5% and up to 9% for such Target Year, the Contingent Purchase Price due to Seller for such Target Year will range from $488,889 371,694 to $1,222,221929,233, determined in accordance with Schedule 2.5.
iii. equal to or greater than 9% for such Target Year, the Contingent Purchase Price due to Seller for such Target Year will be $1,222,222929,234.
2. Subject to Section 2.5.6, if the increase in EBIT is at least 9% for each and every Target Year, as measured against EBIT for the immediately preceding twelve month period ending July 31, then, in addition to the amount of Contingent Purchase Price otherwise payable under this Section 2.5.2, Seller shall be entitled at the end of the Third Target Year, to an additional payment of Contingent Purchase Price equal to $333,333253,428.
Appears in 1 contract